National Health Investors, Inc.

NHI

US63633D1046

Specialized REITs

Market Closed - Nyse Other stock markets 04:00:01 2024-04-26 pm EDT			5-day change	1st Jan Change
62.89 ^USD	+0.45%		+2.23%	+12.61%

Apr. 18	Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting	CI
Mar. 18	Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating	MT

National Health Investors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

February 20, 2024 at 04:12 pm EST

National Health Investors, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 249.23 million compared to USD 217.7 million a year ago. Revenue was USD 319.84 million compared to USD 278.19 million a year ago.

Net income was USD 135.65 million compared to USD 66.4 million a year ago. Basic earnings per share from continuing operations was USD 3.13 compared to USD 1.48 a year ago. Diluted earnings per share from continuing operations was USD 3.13 compared to USD 1.48 a year ago.

Latest news about National Health Investors, Inc.

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting	Apr. 18	CI
Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating	Mar. 18	MT
North American Morning Briefing : Stock Futures -2-	Mar. 13	DJ
BMO Capital Upgrades National Health Investors to Outperform From Market Perform	Mar. 12	MT
National Health Investors Insider Bought Shares Worth $586,882, According to a Recent SEC Filing	Feb. 29	MT
North American Morning Briefing : Stock Futures -2-	Feb. 27	DJ
National Health Investors Shares Rise After Wells Fargo, Wedbush Upgrade	Feb. 26	MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Price Target is $63	Feb. 26	MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Adjusts Price Target to $63 From $55	Feb. 26	MT
Wedbush Upgrades National Health Investors to Outperform From Neutral, Says More Optimistic on Skilled Nursing Facilities/Senior Housing; Raises PT to $64 From $57	Feb. 26	MT
Transcript : National Health Investors, Inc., Q4 2023 Earnings Call, Feb 21, 2024	Feb. 21
National Health Investors' Q4 Normalized FFO, Revenue Rise; 2024 Outlook Issued	Feb. 21	MT
Earnings Flash (NHI) NATIONAL HEALTH INVESTORS Reports Q4 Revenue $79.5M	Feb. 20	MT
National Health Investors, Inc. Provides Earnings Guidance for the Year 2024	Feb. 20	CI
National Health Investors, Inc. Announces First Quarter Dividend, Payable on May 3, 2024	Feb. 20	CI
National Health Investors, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 20	CI
Tranche Update on National Health Investors, Inc.'s Equity Buyback Plan announced on February 21, 2023.	Feb. 20	CI
National Health Investors, Inc. announces an Equity Buyback for $160 million worth of its shares.	Feb. 20	CI
National Health Investors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Tranche Update on National Health Investors, Inc.'s Equity Buyback Plan announced on February 21, 2023.	Feb. 20	CI
National Health Investors, Inc.'s Equity Buyback announce on February 21, 2023, has expired with 0 shares, representing 0% for $0 million.	Feb. 15	CI
National Health Investors, Inc. authorizes a Buyback Plan.	Feb. 15	CI
Deutsche Bank Initiates Coverage on National Health Investors With Buy Rating, $69 Price Target	Jan. 30	MT
Wells Fargo Adjusts National Health Investors' Price Target to $55 From $54, Maintains Equal-Weight Rating	Nov. 27	MT
Transcript : National Health Investors, Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08

Chart National Health Investors, Inc.

Duration

Period

More charts

Company Profile

National Health Investors, Inc. is a real estate investment trust. The Company specializes in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and lease, mortgage, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has 163 healthcare real estate properties located in 31 states and leased primarily pursuant to triple-net leases to 25 tenants. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The SHOP segment has 15 properties located in eight states with a combined 1,733 units.

Sector

Specialized REITs

Calendar

2024-05-05 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for National Health Investors, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

62.89 USD

Average target price

62.83 USD

Spread / Average Target

-0.09%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Healthcare REITs

	1st Jan change	Capi.
NATIONAL HEALTH INVESTORS, INC.	+12.61%	2.73B
WELLTOWER INC.	+4.62%	55.76B
VENTAS, INC.	-11.72%	17.72B
HEALTHPEAK PROPERTIES, INC.	-5.05%	13.23B
OMEGA HEALTHCARE INVESTORS, INC.	+1.40%	7.68B
HEALTHCARE REALTY TRUST INCORPORATED	-16.54%	5.39B
CARETRUST REIT, INC.	+8.62%	3.28B
SABRA HEALTH CARE REIT, INC.	-2.31%	3.23B
AEDIFICA SA	-5.42%	3.06B
MEDICAL PROPERTIES TRUST, INC.	-8.15%	2.73B

Healthcare REITs